- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 40.41M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $4.12M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.14M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $89K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $88K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $93.3M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $84.09M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $433.98M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $427.83M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $439.92M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $434.58M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $504.89M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $491.54M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $534.19M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $519.67M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $32.63M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $2.86M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 39.77M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $28K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$46.97M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.09 |
| Operating Income | Q1 2025 · Mar 31, 2024 | $5.1M |
| Revenue | Q1 2025 · Mar 31, 2024 | $20.46M |